Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,066,843    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $65,005,693      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 29 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-04 4 AS $88.00 $440,000 D/D (5,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-22 4 D $88.05 $1,155,832 D/D (13,127) 323,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-08-07 4 S $88.10 $352,400 D/D (4,000) 428,732 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-29 4 AS $88.18 $132,270 D/D (1,500) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-09 4 AS $88.28 $1,324,200 D/D (15,000) 419,602 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-31 4 AS $88.29 $655,377 D/D (7,423) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-15 4 AS $88.29 $1,655,434 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-08-08 4 S $88.29 $529,740 D/D (6,000) 422,732 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-24 4 AS $88.38 $441,900 D/D (5,000) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-11 4 AS $88.42 $1,657,856 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-17 4 AS $88.66 $1,662,356 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-24 4 AS $88.73 $266,193 I/I (3,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-24 4 AS $88.73 $177,462 D/D (2,000) 227,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-28 4 AS $88.77 $133,155 D/D (1,500) 297,052 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-11 4 AS $88.96 $444,780 D/D (5,000) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-12 4 AS $89.00 $445,000 D/D (5,000) 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-12 4 AS $89.12 $356,480 D/D (4,000) 325,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-16 4 AS $89.13 $1,671,131 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-14 4 AS $89.22 $1,672,851 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-21 4 A $89.22 $8,922 D/D 100 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-12 4 AS $89.23 $446,150 D/D (5,000) 238,496 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-01 4 AS $89.38 $357,520 D/D (4,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-09 4 AS $89.52 $895,200 D/D (10,000) 296,443 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-03-03 4 D $89.57 $805,145 D/D (8,989) 331,511 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-10 4 AS $89.59 $1,679,794 D/D (18,750) 290,600 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29  30   31   32   33   34   35      
  Page 29 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us